|Bid||14.51 x 1000|
|Ask||40.00 x 1000|
|Day's Range||35.58 - 36.72|
|52 Week Range||32.43 - 62.27|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||122.33|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Despite solid IVD revenues, Surmodics (SRDX) reports a soft Q2 overall top line.
SurModics (SRDX) delivered earnings and revenue surprises of 31.25% and 6.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...